Disease-modifying anti-asthmatic drugs

医学 哮喘 氨茶碱 茶碱 不利影响 支气管扩张剂 重症监护医学 内科学
作者
Marek Lommatzsch,Guy Brusselle,Giorgio Walter Canonica,David J. Jackson,Parameswaran Nair,Roland Buhl,J. Christian Virchow
出处
期刊:The Lancet [Elsevier BV]
卷期号:399 (10335): 1664-1668 被引量:132
标识
DOI:10.1016/s0140-6736(22)00331-2
摘要

Drugs available for asthma treatment in the first decades of the 20th century (sympathomimetic agents such as oral ephedrine, intravenous adrenaline, or inhaled epinephrine; anticholinergics such as inhaled scopolamine; methylxanthines such as oral caffeine or theophylline 1 von Mutius E Drazen JM A patient with asthma seeks medical advice in 1828, 1928, and 2012. N Engl J Med. 2012; 366: 827-834 Crossref PubMed Scopus (29) Google Scholar ) aimed at relieving acute and life-threatening airway obstruction, but did not target the underlying pathophysiology of asthma (which was unknown at that time) and were not intended to induce any long-term therapeutic benefit. Systemic glucocorticoids and inhaled short-acting beta-2 agonists were introduced in the 1950s with the same concept of symptom relief. 2 Schwartz E Oral cortisone therapy in intractable bronchial asthma. J Am Med Assoc. 1951; 147: 1734-1737 Crossref PubMed Scopus (8) Google Scholar , 3 Burrage WS Irwin JW The role of cortisone in the treatment of severe bronchial asthma. N Engl J Med. 1953; 248: 679-682 Crossref PubMed Scopus (1) Google Scholar , 4 Cander L Comroe Jr, JH A method for the objective evaluation of bronchodilator drugs: effects of dapanone, isuprel, and aminophylline in patients with bronchial asthma. J Allergy. 1955; 26: 210-218 Summary Full Text PDF PubMed Scopus (13) Google Scholar Additionally, systemic glucocorticoids were associated with severe adverse effects and inhaled short-acting beta-2 agonists were associated with increased mortality. 5 Ekström M Nwaru BI Hasvold P Wiklund F Telg G Janson C Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden. Allergy. 2019; 74: 2181-2190 Crossref PubMed Scopus (43) Google Scholar , 6 Pearce N Beasley R Crane J Burgess C Jackson R End of the New Zealand asthma mortality epidemic. Lancet. 1995; 345: 41-44 Summary PubMed Scopus (155) Google Scholar , 7 Inman WH Adelstein AM Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969; 2: 279-285 Summary PubMed Google Scholar , 8 Johnston SL Edwards MR Mechanisms of adverse effects of {beta}-agonists in asthma. Thorax. 2009; 64: 739-741 Crossref PubMed Scopus (30) Google Scholar , 9 Spitzer WO Suissa S Ernst P et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992; 326: 501-506 Crossref PubMed Scopus (1060) Google Scholar , 10 Sears MR Taylor DR Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990; 336: 1391-1396 Summary PubMed Scopus (860) Google Scholar Cromones, available since the 1960s, 11 Howell JB Altounyan RE A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet. 1967; 2: 539-542 Summary PubMed Google Scholar had an acceptable safety profile, but inferior efficacy compared with even low doses of inhaled corticosteroids. 12 Guevara JP Ducharme FM Keren R Nihtianova S Zorc J Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. Cochrane Database Syst Rev. 2006; 2006Cd003558 Google Scholar Thus, until the 1970s, maintenance treatment of asthma was based on a regular application of reliever therapies, which were either associated with side-effects or had limited clinical efficacy. Furthermore, due to non-specific modes of action and few alternative options, any appreciation that clinical phenotypes of asthma existed was mainly academic: a one-size-fits-all approach was applied for every patient with asthma (figure).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
洽洽瓜子shine完成签到,获得积分10
刚刚
太阳女神完成签到,获得积分10
刚刚
wary关注了科研通微信公众号
1秒前
wwwy完成签到,获得积分10
2秒前
昏睡的坚果完成签到 ,获得积分10
2秒前
Rming完成签到,获得积分10
2秒前
ilucce完成签到,获得积分10
2秒前
pihriyyy完成签到,获得积分10
3秒前
meimei完成签到,获得积分10
4秒前
董ww完成签到 ,获得积分10
4秒前
4秒前
Dogged完成签到 ,获得积分10
5秒前
坚强的翠容完成签到,获得积分10
6秒前
向往的鱼完成签到 ,获得积分10
6秒前
猜不猜不完成签到 ,获得积分10
7秒前
7秒前
聪慧的迎夏完成签到,获得积分10
7秒前
哈哈哈哈完成签到,获得积分10
8秒前
秋风的应助被仁爱的沁采纳,获得110
9秒前
遮天完成签到,获得积分10
10秒前
生物科研小白完成签到 ,获得积分10
10秒前
机灵瑛完成签到,获得积分10
10秒前
茴香发布了新的文献求助10
11秒前
franklylyly完成签到,获得积分10
12秒前
KOW完成签到 ,获得积分10
12秒前
Luuuuu完成签到 ,获得积分10
12秒前
行走完成签到,获得积分10
13秒前
隐形曼青的应助被云清采纳,获得10
13秒前
大方颦完成签到 ,获得积分10
14秒前
XuNan完成签到,获得积分10
16秒前
研友_VZG7GZ的应助被风吹麦浪采纳,获得10
16秒前
17秒前
单纯乞完成签到,获得积分10
17秒前
Yanjiakun完成签到,获得积分10
19秒前
定位心海的锚完成签到,获得积分10
19秒前
屿鑫完成签到,获得积分10
20秒前
liu完成签到 ,获得积分10
21秒前
62170023完成签到,获得积分10
22秒前
23秒前
Alawys完成签到 ,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185571
求助须知:如何正确求助?哪些是违规求助? 9574336
关于积分的说明 21835187
捐赠科研通 7783367
什么是DOI,文献DOI怎么找? 3434606
关于科研通互助平台的介绍 2558985
邀请新用户注册赠送积分活动 2481374